Kimberly-Clark is buying Tylenol maker Kenvue in cash and stock deal worth –$48B
apnews.comWould be interesting to see whether and how anyone at Kimberly-Clark, or any of its shareholders, cozied up to Trump and/or RFK Jr. before the whole MAHA "acetaminophen causes autism" bit happened; and when, exactly, Kimberly Clark started looking into acquiring Kenvue.
Not sure where the '-' came from, it's regular +$48b
Ah crap. I tried to put ~ since the original headline had the word "about" but I must have typo'd.